Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Web Exclusives
Radiotherapy Revolution: Three Must-Read Studies Transforming Cancer Care
By
Hina M. Porcelli
Radiotherapy in Focus
Web Exclusives
— September 24, 2025
Learn about how clinical research trials are revolutionizing radiotherapy, leading to advancements reshaping cancer care for better patient outcomes and experiences.
Read Article
Prior Authorization Payer Changes, Hope or Hype?
By
Dawn Holcombe, MBA, FACMPE, ACHE
Policies & Guidelines
Web Exclusives
— August 26, 2025
A coalition of more than 40 health insurers recently announced plans for prior authorization reform.
Read Article
HHS Takes Aim at Prior Authorizations
Value-Based Care
Web Exclusives
— July 22, 2025
In a roundtable discussion hosted by HHS, health insurers pledged 6 key reforms they say are designed to cut red tape, accelerate care decisions, and enhance
Read Article
Redesigning Access: S2302 Pragmatica-Lung Study as a Model for Inclusive Cancer Trials
By
Meg Barbor, MPH
ASCO
,
ASCO Conference
,
Clinical Trials
Web Exclusives
— June 13, 2025
The phase 3 S2302 Pragmatica-Lung study offers a new blueprint for cancer clinical trials, one that emphasizes simplification, inclusivity, and real-world applicability, according to Konstantin Dragnev, MD, of Dartmouth Cancer Center.
Read Article
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Value-Based Care
Web Exclusives
— April 8, 2025
Paula Aristizabal, MD, MAS, a pediatric hematologist/oncologist at Rady Children’s Hospital-San Diego/associate professor at the University of California San Diego, and her research team developed a peer navigation intervention known as the Childhood Malignancy Peer Research Navigation (Comprendo) program. This program pairs trained parent navigators—individuals who have experienced similar challenges with their own children’s cancer care—with parents who are newer to the experience, with the intention to guide these families through the informed consent process for childhood cancer clinical trials.
Read Article
Disparities Noted in Treatment and Outcomes for Hormone Receptor–Positive/HER2-Negative Metastatic Breast Cancer
Breast Cancer
Web Exclusives
— March 21, 2025
n the US cohort, Black patients with HR-positive/HER2-negative mBC who underwent NGS testing were more likely to receive first-line chemotherapy, less likely to have PIK3CA mutations, and less likely to receive first-line CDK4/6 inhibitors compared with White patients.
Read Article
Genetic Changes, Elevated Leukemia Risk in Ground Zero First Responders
Leukemia
Web Exclusives
— March 21, 2025
round Zero were 3 times more likely to have genetic changes associated with an increased risk of blood cancer compared with other first responders.
Read Article
Study: Driving Distance From VA Hospital Influenced Cancer Care
Oncology
,
Multiple Myeloma
Web Exclusives
— February 27, 2025
The researchers noted variations in time to treatment initiation and choice of therapy across the 3 healthcare settings, with factors such as distance from the hospital and income levels playing significant roles in delays of treatment.
Read Article
Billing for Navigation Services
Economics of Cancer Care
Web Exclusives
— January 17, 2025
Following the conclusion of the OCM, which previously compensated nurses providing navigation services, practices nationwide faced revenue loss and had to adapt nurse assignments accordingly. Despite these financial setbacks, the demand for navigation services remains high due to their pivotal role in patient care and support.
Read Article
2025 ICD-10-CM Coding Update
Value-Based Care
,
Reimbursement
Web Exclusives
— December 12, 2024
The specificity of ICD-10-CM codes allows providers to communicate correct clinical information to third-party payers and across the healthcare continuum.
Read Article
Page 2 of 13
1
2
3
4
5
Top Trending Articles
1.
ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
Meg Barbor, MPH
2.
The Evolving Landscape of Lung Cancer Care
Meg Barbor, MPH
3.
AUGTYRO (Repotrectinib) for the Treatment of ROS1-Positive Non-Small Cell Lung Cancer
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma